Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

Clicks: 441
ID: 111830
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #25 of 105 articles by views in Antimicrobial agents and chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Several investigators have suggested that the 24-h area under the concentration-time curve (AUC)/MIC ratio (AUC/MIC24 or AUIC24) can be used to make comparisons of antimicrobial activity between fluoroquinolone antibiotics. Limited data exist regarding the generic predictive ability of AUC/MIC24 for …
Reference Key
kj1996antimicrobialtwenty-four-hour Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Madaras-Kelly KJ, Ostergaard BE, Hovde LB, Rotschafer JC
Are you one of these authors? Claim your profile
Journal Antimicrobial agents and chemotherapy
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8851583
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine models research support non-u.s. gov't regression analysis microbial sensitivity tests pseudomonas aeruginosa / drug effects* biological kinetics ofloxacin / pharmacology anti-infective agents / pharmacology* pmid:8851583 pmc163170 doi:10.1128/aac.40.3.627 k j madaras-kelly b e ostergaard j c rotschafer anti-infective agents / pharmacokinetics ciprofloxacin / pharmacokinetics ciprofloxacin / pharmacology ofloxacin / pharmacokinetics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.